Conversely, other studies have reported that PD patients with peripheral immunological alterations exhibit a reduced percentage of T lymphocytes (CD3+ cells), particularly activated T lymphocytes (CD4+CD25+ cells) (Cen et al., 2017; Rocha et al., 2017; Sun et al., 2019). The gene discussed is CD4; the disease is Parkinson disease.